Straumann Holding AG (OTCMKTS:SAUHY) Given Average Rating of “Hold” by Analysts

Shares of Straumann Holding AG (OTCMKTS:SAUHYGet Free Report) have been given a consensus recommendation of “Hold” by the six brokerages that are currently covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a sell recommendation, two have issued a hold recommendation, one has given a buy recommendation and one has given a strong buy recommendation to the company.

SAUHY has been the subject of a number of research reports. Morgan Stanley reaffirmed an “underweight” rating on shares of Straumann in a report on Monday, December 15th. Deutsche Bank Aktiengesellschaft raised shares of Straumann from a “hold” rating to a “buy” rating in a research report on Friday, October 31st. UBS Group upgraded shares of Straumann from a “sell” rating to a “neutral” rating in a research note on Tuesday, November 4th. Finally, Citigroup reiterated a “sell” rating on shares of Straumann in a research note on Wednesday, January 14th.

Get Our Latest Report on Straumann

Straumann Stock Down 1.9%

Shares of SAUHY opened at $12.66 on Monday. The stock has a 50-day moving average of $12.12 and a two-hundred day moving average of $11.82. Straumann has a one year low of $10.30 and a one year high of $15.00.

About Straumann

(Get Free Report)

Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.

Featured Stories

Analyst Recommendations for Straumann (OTCMKTS:SAUHY)

Receive News & Ratings for Straumann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Straumann and related companies with MarketBeat.com's FREE daily email newsletter.